Search Results

Filter
  • 1-10 of  21 results for ""CYTOCHROME P-450 CYP2C19""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.

Subjects: Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/genetics ; Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/Cytochrome P-450 CYP2C19*/metabolism ; Purinergic P2Y Receptor Antagonists*/Purinergic P2Y Receptor Antagonists*/Purinergic P2Y Receptor Antagonists*/therapeutic use

  • Source: Circulation [Circulation] 2024 Aug 06; Vol. 150 (6), pp. e129-e150. Date of Electronic Publication: 2024 Jun 20.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.

  • Authors : Pan Y; From Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China (Y.P., W.C., X.Z., L.L., Q.Z., G.W., Yongjun Wang, Yilong Wang); China National Clinical Research Center for Neurological Diseases, Beijing (Y.P., W.C., X.Z., L.L., Q.Z., G.W., Yongjun Wang, Yilong Wang)

Subjects: Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*genetics ; Ischemic Attack, Transient/Ischemic Attack, Transient/Ischemic Attack, Transient/*genetics ; Stroke/Stroke/Stroke/*genetics

  • Source: Circulation [Circulation] 2017 Jan 03; Vol. 135 (1), pp. 21-33. Date of Electronic Publication: 2016 Nov 02.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?

  • Authors : Maamari DJ; Center for Genomic Medicine (D.J.M., A.V.K., A.C.F.), Massachusetts General Hospital.; Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge (D.J.M., A.V.K., A.C.F.).

Subjects: Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/drug therapy ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/genetics ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects

  • Source: Circulation [Circulation] 2022 Mar 08; Vol. 145 (10), pp. 721-723. Date of Electronic Publication: 2022 Mar 07.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Cilostazol/Cilostazol/Cilostazol/*therapeutic use ; Clopidogrel/Clopidogrel/Clopidogrel/*therapeutic use

  • Source: Circulation [Circulation] 2018 May 22; Vol. 137 (21), pp. 2231-2245. Date of Electronic Publication: 2018 Feb 02.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Clinical Impact of Pharmacogenomics of Clopidogrel in Stroke.

  • Authors : Simon T; From French Alliance for Cardiovascular Trials, an F-CRIN Network, DHU FIRE, Paris, France (T.S., N.C.); INSERM U1148, Paris, France (T.S.)

Subjects: Pharmacogenetics* ; Ticlopidine*/Ticlopidine*/Ticlopidine*/analogs & derivatives; Clopidogrel

  • Source: Circulation [Circulation] 2017 Jan 03; Vol. 135 (1), pp. 34-37.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: the role of platelet reactivity and genotype testing in the prevention of atherothrombotic cardiovascular events remains unproven.

  • Authors : Krishna V; Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Diamond GA

Subjects: Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*therapeutic use ; Genetic Testing/Genetic Testing/Genetic Testing/*standards ; Pharmacogenetics/Pharmacogenetics/Pharmacogenetics/*standards

  • Source: Circulation [Circulation] 2012 Mar 13; Vol. 125 (10), pp. 1288-303; discussion 1303.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.

  • Authors : Gurbel PA; Sinai Center for Thrombosis Research, Baltimore, MD 21215, USA. ; Tantry US

Subjects: Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*therapeutic use ; Genetic Testing/Genetic Testing/Genetic Testing/*standards ; Pharmacogenetics/Pharmacogenetics/Pharmacogenetics/*standards

  • Source: Circulation [Circulation] 2012 Mar 13; Vol. 125 (10), pp. 1276-87; discussion 1287.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.

  • Authors : Simon T; Department of Pharmacology, Clinical Research Unit, APHP, St. Antoine Hospital, UMPC-Paris 06 University, 27 Rue Chaligny, Paris, France. ; Steg PG

Subjects: Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/*genetics ; Myocardial Infarction/Myocardial Infarction/Myocardial Infarction/*drug therapy ; Myocardial Infarction/Myocardial Infarction/Myocardial Infarction/*epidemiology

  • Source: Circulation [Circulation] 2011 Feb 08; Vol. 123 (5), pp. 474-82. Date of Electronic Publication: 2011 Jan 24.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

CYP2C19 genotype and proton pump inhibitors in clopidogrel-treated patients: does it take two to tango?

Subjects: Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/Aryl Hydrocarbon Hydroxylases/*genetics ; Proton Pump Inhibitors/Proton Pump Inhibitors/Proton Pump Inhibitors/*therapeutic use ; Ticlopidine/Ticlopidine/Ticlopidine/*analogs & derivatives

  • Source: Circulation [Circulation] 2011 Feb 08; Vol. 123 (5), pp. 468-70. Date of Electronic Publication: 2011 Jan 24.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  21 results for ""CYTOCHROME P-450 CYP2C19""